AMPICILLIN AND SULBACTAM

Generic: AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM AND SULBACTAM SODIUM

Sagent PharmaceuticalsManufacturer
INTRAVENOUSRoute
AMPICILLIN SODIUMActive Substance
2009-12-23Original Approval

AMPICILLIN AND SULBACTAM is FDA application ANDA065403, sponsored by ACS DOBFAR. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DRUG INEFFECTIVE
86 reports
2
PYREXIA
71 reports
3
OFF LABEL USE
54 reports
4
PNEUMONIA
49 reports
5
CONDITION AGGRAVATED
43 reports
6
MULTIPLE ORGAN DYSFUNCTION SYNDROME
33 reports
7
SEPSIS
31 reports
8
ACUTE KIDNEY INJURY
30 reports
9
SEPTIC SHOCK
30 reports
10
DYSPNOEA
29 reports